Barings’s Innoviva INVA Stock Holding History

Barings’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-30,900	Closed	-$515K	–	864
2018 Q1	$515K	Buy	+30,900	New	+$477K	0.01%	686

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barings's INVA Position: Q2 2018 in Review

Barings sold out of Innoviva (INVA) in Q2 2018, closing a stake of 30,900 shares — an estimated $515K sold.

Barings first reported a position in INVA in Q1 2018 and held it in 1 quarter. The position peaked at $515K in Q1 2018. 224 funds tracked by Wall St. Rank hold INVA as of Q2 2018.

Barings reported no remaining Innoviva position as of Q2 2018 after selling out during the quarter.
Barings sold 30,900 Innoviva shares in Q2 2018, an estimated $515K.
Barings first reported a position in Innoviva in Q1 2018 and held it in 1 quarter.
Barings's Innoviva position peaked at $515K in Q1 2018.
224 funds tracked by Wall St. Rank held Innoviva as of Q2 2018.

Based on Barings's 13F filing for Q2 2018, filed 3 Aug 2018.